Currently recruiting clinical trials for GIST in the Chicago Area:
Click on the trial NCT # to go to the LRG Clinical Trial database listing for additional data and contact info.
- NCT03673501 Phase 3 DCC-2618 versus Sunitinib: Lurie CCC and University of Chicago
- NCT03411915 Phase 1 XmAb18087 anti-SSTR2/CD3 monoclonal antibody: Northwestern Medicine zip 60611
- NCT02568267 Phase 2 Entrectinib for NTRK Fusions: NWU Chicago, Advocate Park Ridge, Midwestern RMC Zion
- NCT02576431 Phase 2 LOXO-101 for NTRK Fusions: Univ. of Chicago